Zobrazeno 1 - 10
of 243
pro vyhledávání: '"G.G. Neri Serneri"'
Autor:
Domenico Prisco, Rita Paniccia, Isa Francalanci, M. Filippini, Gian Franco Gensini, K Abbate, G.G. Neri Serneri
Publikováno v:
The American Journal of Clinical Nutrition. 63:925-932
To characterize the time course of plasma and red blood cell (RBC) changes after n-3 polyunsaturated fatty acid (PUFA) supplementation, 20 healthy male volunteers were randomly assigned to receive either four 1-g capsules of n-3 PUFA ethyl esters or
Autor:
Giovanni Melandri, Gian Franco Gensini, M. Carnovali, Loredana Poggesi, Carlo Rostagno, Angelo Branzi, G.G. Neri Serneri, Bruno Magnani, C. Tamburini, Pietro Amedeo Modesti
Publikováno v:
The Lancet. 345:1201-1204
Intravenous heparin has been used in the control of myocardial ischaemia in patients with unstable angina. We set out to assess the efficacy of subcutaneous heparin in reducing myocardial ischaemia in patients with unstable angina. 343 of 399 patient
Autor:
L Arata, A Dagianti, Mirella Coppo, Gian Franco Gensini, G.G. Neri Serneri, P Dabizzi, S Lazzerini, M Bini, Carlo Rostagno, Maria Boddi
Publikováno v:
Scopus-Elsevier
BACKGROUND Inferential evidence suggests that silent ischemia might be related to sympathetic activity. Study of [3H]norepinephrine kinetics is a suitable tool to assess the regional sympathetic activity. This method was applied to investigate whethe
Autor:
Rosanna Abbate, Carlo Rostagno, Domenico Prisco, G.F. Gensini, Mirella Coppo, Maria Boddi, G.G. Neri Serneri
Publikováno v:
Thrombosis Research. 63:457-462
Publikováno v:
Scopus-Elsevier
Università degli studi di Firenze-IRIS
Università degli studi di Firenze-IRIS
Heparin and antiaggregating therapy represent an effective treatment of unstable angina. Aspirin is able to prevent myocardial infarction and death in patients with unstable angina, but is not able to control myocardial ischemia. On the contrary, hep
Autor:
G. Pezzuoli, G.G. Neri Serneri, G. Coggi, N. Olivari, Giampiero Negri, G. Galli, Piergiorgio Settembrini, Codemo R, S. Roveri
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 20:193-204
Deep venous thrombosis is very frequent after general surgery, and its major complication, pulmonary embolism, is today the most frequent cause of postoperative death. The reduction of this cause of mortality is mainly based on its prevention rather
Autor:
P.G. Settembrini, I. Caramazza, Rosanna Abbate, Anna Maria Gori, K.-H. Usadel, G. Coggi, Sergio Coccheri, Valentin Fuster, R. Codemo, Domenico Prisco, Colin R. M. Prentice, Pietro Amedeo Modesti, H.C. Hemker, J. Harenberg, G. Zoppetti, Rita Paniccia, Monica Attanasio, G.G. Neri Semen, M. Lettino, K. Mall, A.L. Bloom, S. Roveri, G. Talarico, G. Galli, P. Prandoni, D.L. Heene, H. Bratsch, G. Stehle, F.A. Ofosu, Marc Verstraete, Ira M. Herman, E. Ambrosioni, M. Vigo, M. Bossi, N. Olivari, R. Lamberti, Ulf Lindahl, K.T. Preissner, G. Pezzuoli, Francesca Martini, Domenico Inzitari, Ilaria Cecioni, G. Andriuoli, E. Strocchi, K. Huck, Francesco Bonechi, A. Lotto, G.G. Neri Serneri, Luigi Amaducci, Alberto Fortini, S. Béguin, A.M. Cattelan, Luigi Tavazzi, B. Casu, G.F. Gensini, A. Ruol, G. Fratianni, G. Negri, Marc Cohen, Andrea Colella, A. Colombo, Betti Giusti, M. Blauth, Patricia A. D’Amore, Ce. Dempfle
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 20:I-V
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 20:142-144
Publikováno v:
Heart-Brain Interactions ISBN: 9783642766541
Heparin and oral anticoagulant drugs are used in treating cerebrovascular disease or acute myocardial ischemia because heparin can prevent blood clotting or thrombus formation. Both in cerebrovascular disease and in coronary artery disease, thrombus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62aa927840ba983092b08fbd98a9a823
https://doi.org/10.1007/978-3-642-76652-7_20
https://doi.org/10.1007/978-3-642-76652-7_20
Autor:
Rosanna Abbate, Pietro Amedeo Modesti, Gian Franco Gensini, Andrea Colella, G.G. Neri Serneri, Ilaria Cecioni
Publikováno v:
Scopus-Elsevier
1. Picotamide has been shown to interfere competitively with the thromboxane A2 (TxA2) platelet receptor. In the present study the effect of in vivo administration of picotamide on TxA2 human platelet receptors was investigated in 10 healthy subjects